| Return on average equity - 5 year average | 20.84 |
| Net Income/employee - trailing 12 month | 13,02,124.00 |
| Revenue/employee - most recent fiscal year | 72,36,773.00 |
| Return on investment - most recent fiscal year | 19.49 |
| Return on average assets - most recent fiscal year | 15.96 |
| Receivables turnover - most recent fiscal year | 5.21 |
| Return on investment - trailing 12 month | 19.30 |
| Return on average assets - trailing 12 month | 16.44 |
| Inventory turnover - most recent fiscal year | 2.68 |
| Inventory turnover - trailing 12 month | 2.38 |
| Revenue/employee - trailing 12 month | 74,16,728.00 |
| Return on average assets - 5 year average | 15.91 |
| Net Income/employee - most recent fiscal year | 12,18,289.00 |
| Return on average equity - trailing 12 month | 20.47 |
| Receivables turnover - trailing 12 month | 4.67 |
| Asset turnover - most recent fiscal year | 0.95 |
| Asset turnover - trailing 12 month | 0.94 |
| Return on average equity - most recent fiscal year | 20.75 |
| Return on investment - 5 year average | 19.18 |
J B Chemicals and Pharmaceuticals Dividend J B Chemicals and Pharmaceuticals Bonus J B Chemicals and Pharmaceuticals News J B Chemicals and Pharmaceuticals AGM J B Chemicals and Pharmaceuticals Rights J B Chemicals and Pharmaceuticals Splits J B Chemicals and Pharmaceuticals Board Meetings J B Chemicals and Pharmaceuticals Shareholdings J B Chemicals and Pharmaceuticals Profit Loss J B Chemicals and Pharmaceuticals Balance Sheet J B Chemicals and Pharmaceuticals Cashflow J B Chemicals and Pharmaceuticals Q1 Results J B Chemicals and Pharmaceuticals Q2 Results J B Chemicals and Pharmaceuticals Q3 Results J B Chemicals and Pharmaceuticals Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks